HAL (France)open access
SGLT2 Inhibitors in Hypertrophic Cardiomyopathy: Emerging Evidence and Putative Mechanisms
1, 0, 2, Gliflozines hypertrophic cardiomyopathy inflammation reactive oxygen species sodium–glucose cotransporter 2 inhibitors
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 480434
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.